70 related articles for article (PubMed ID: 19407336)
1. Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures.
Bjork JA; Wallace KB
Toxicol Sci; 2009 Sep; 111(1):89-99. PubMed ID: 19407336
[TBL] [Abstract][Full Text] [Related]
2. Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators.
Tamasi V; Miller KK; Ripp SL; Vila E; Geoghagen TE; Prough RA
Mol Pharmacol; 2008 Mar; 73(3):968-76. PubMed ID: 18079279
[TBL] [Abstract][Full Text] [Related]
3. Perfluorinated Alkyl Acids in Hawaiian Cetaceans and Potential Biomarkers of Effect: Peroxisome Proliferator-Activated Receptor Alpha and Cytochrome P450 4A.
Kurtz AE; Reiner JL; West KL; Jensen BA
Environ Sci Technol; 2019 Mar; 53(5):2830-2839. PubMed ID: 30681325
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor alpha-dependent induction of cell surface antigen Ly-6D gene in the mouse liver.
Dadras SS; Cook WS; Yeldandi AV; Cao WQ; Rao MS; Wang Z; Reddy JK
Gene Expr; 2001; 9(4-5):173-81. PubMed ID: 11444527
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis.
Yang Q; Ito S; Gonzalez FJ
Carcinogenesis; 2007 Jun; 28(6):1171-7. PubMed ID: 17331954
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor α agonist induces mouse hepatomegaly through the spatial hepatocyte enlargement and proliferation.
Yang J; Yang X; Zhang YF; Tian JN; Fan SC; Gao Y; Li HL; Cai CH; Huang M; Bi HC
Acta Pharmacol Sin; 2023 Oct; 44(10):2037-2047. PubMed ID: 37193756
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships for perfluoroalkane-induced in vitro interference with rat liver mitochondrial respiration.
Wallace KB; Kissling GE; Melnick RL; Blystone CR
Toxicol Lett; 2013 Oct; 222(3):257-64. PubMed ID: 23954199
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Mode of Action Underlying the Effects of GenX in Mouse Liver and Implications for Assessing Human Health Risks.
Chappell GA; Thompson CM; Wolf JC; Cullen JM; Klaunig JE; Haws LC
Toxicol Pathol; 2020 Apr; 48(3):494-508. PubMed ID: 32138627
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the mode of action of perfluorooctanoic acid-induced liver tumors in male Sprague-Dawley rats using a toxicogenomic approach.
Li X; Wang Z; Wu Q; Klaunig JE
J Environ Sci Health C Toxicol Carcinog; 2024 Mar; ():1-25. PubMed ID: 38494990
[TBL] [Abstract][Full Text] [Related]
10. Perfluorooctanoic acid inhibits cell proliferation through mitochondrial damage.
Park EJ; Li K; Kang MS; Choi JW; Baek B; Yang YK; Cho AE; Lee BS
Toxicol In Vitro; 2024 May; 97():105810. PubMed ID: 38513818
[TBL] [Abstract][Full Text] [Related]
11. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in mouse, rat, and pooled human hepatocytes.
Heintz MM; Klaren WD; East AW; Haws LC; McGreal SR; Campbell RR; Thompson CM
Toxicol Sci; 2024 Apr; ():. PubMed ID: 38574381
[TBL] [Abstract][Full Text] [Related]
12. Testing for departures from additivity in mixtures of perfluoroalkyl acids (PFAAs).
Carr CK; Watkins AM; Wolf CJ; Abbott BD; Lau C; Gennings C
Toxicology; 2013 Apr; 306():169-75. PubMed ID: 23470359
[TBL] [Abstract][Full Text] [Related]
13. Does exposure to perfluoroalkyl acids present a risk to human health?
Rosen MB; Lau C; Corton JC
Toxicol Sci; 2009 Sep; 111(1):1-3. PubMed ID: 19561327
[No Abstract] [Full Text] [Related]
14. Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort.
Blake BE; Pinney SM; Hines EP; Fenton SE; Ferguson KK
Environ Pollut; 2018 Nov; 242(Pt A):894-904. PubMed ID: 30373035
[TBL] [Abstract][Full Text] [Related]
15. Maternal exposure to perfluorooctanoic acid (PFOA) causes liver toxicity through PPAR-α pathway and lowered histone acetylation in female offspring mice.
Li D; Zhang L; Zhang Y; Guan S; Gong X; Wang X
Environ Sci Pollut Res Int; 2019 Jun; 26(18):18866-18875. PubMed ID: 31062244
[TBL] [Abstract][Full Text] [Related]
16. Mixture Effects of Per- and Polyfluoroalkyl Substances on Embryonic and Larval Sheepshead Minnows (
Tanabe P; Key PB; Chung KW; Pisarski EC; Reiner JL; Rodowa AE; Magnuson JT; DeLorenzo ME
Toxics; 2024 Jan; 12(1):. PubMed ID: 38276726
[TBL] [Abstract][Full Text] [Related]
17. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes.
Sadrabadi F; Alarcan J; Sprenger H; Braeuning A; Buhrke T
Arch Toxicol; 2024 Feb; 98(2):507-524. PubMed ID: 38117326
[TBL] [Abstract][Full Text] [Related]
18. The EU's Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science.
Spyrakis F; Dragani TA
Toxics; 2023 Aug; 11(9):. PubMed ID: 37755732
[TBL] [Abstract][Full Text] [Related]
19. PFAS Exposures and the Human Metabolome: A Systematic Review of Epidemiological Studies.
India-Aldana S; Yao M; Midya V; Colicino E; Chatzi L; Chu J; Gennings C; Jones DP; Loos RJF; Setiawan VW; Smith MR; Walker RW; Barupal D; Walker DI; Valvi D
Curr Pollut Rep; 2023 Sep; 9(3):510-568. PubMed ID: 37753190
[TBL] [Abstract][Full Text] [Related]
20. Public health evaluation of PFAS exposures and breastfeeding: a systematic literature review.
Hoadley L; Watters M; Rogers R; Siegmann Werner L; Markiewicz KV; Forrester T; McLanahan ED
Toxicol Sci; 2023 Jul; 194(2):121-137. PubMed ID: 37228093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
